Imaging mass spectrometry analysis for follicular lymphoma grading

Follicular lymphoma (FL) is the second most common non-Hodgkins lymphoma in the United States. While the current diagnosis depends heavily on the review of H&E-stained tissues, additional sources of information such as IHC are occasionally needed. Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) can be used to generate protein profiles from localized tissue regions, thus making it possible to relate changes in tissue histology to the changes in the protein signature of the tissue. It may be possible to determine potential biomarkers that can indicate disease state and prognosis based on the protein profile. This research aims to combine two different but related types of data in order to develop a unique diagnosis methodology that can potentially improve the accuracy of diagnosis. Preliminary analysis has shown promising results for distinguishing intrafollicle regions from the mantle and follicle zones in normal tissue.

[1]  N. Otsu.  A threshold selection method from gray level histograms , 1979 .

[2]  James Olen Armitage,et al.  A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. , 1997, Blood.

[3]  M. Stoeckli,et al.  Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues , 2001, Nature Medicine.

[4]  D. Hossfeld.  E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .

[5]  Dean Billheimer,et al.  Integrating histology and imaging mass spectrometry. , 2004, Analytical chemistry.

[6]  Roy A Jensen,et al.  Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. , 2004, The American journal of pathology.

[7]  Yu Shyr,et al.  Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. , 2005, Cancer research.

[8]  Habtom W. Ressom,et al.  Analysis of MALDI-TOF Serum Profiles for Biomarker Selection and Sample Classification , 2005, 2005 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology.

[9]  Richard M Caprioli,et al.  MALDI mass spectrometry for direct tissue analysis: a new tool for biomarker discovery. , 2005, Journal of proteome research.

[10]  Richard M. Caprioli,et al.  Imaging Mass Spectrometry: Principles and Potentials , 2005, Toxicologic pathology.

[11]  Richard M Caprioli,et al.  A Novel Histology-directed Strategy for MALDI-MS Tissue Profiling That Improves Throughput and Cellular Specificity in Human Breast Cancer* , 2006, Molecular & Cellular Proteomics.

[12]  Frank-Michael Schleif,et al.  Statistical Classification and Visualization of MALDI-Imaging Data , 2007, Twentieth IEEE International Symposium on Computer-Based Medical Systems (CBMS'07).

[13]  Pierre P Massion,et al.  High‐throughput proteomic analysis of formalin‐fixed paraffin‐embedded tissue microarrays using MALDI imaging mass spectrometry , 2008, Proteomics.

[14]  Jun Kong,et al.  Computerized microscopic image analysis of follicular lymphoma , 2008, SPIE Medical Imaging.

[15]  Baogang J. Xu,et al.  Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS. , 2008, Journal of proteome research.

[16]  Joel H. Saltz,et al.  Histopathological Image Analysis Using Model-Based Intermediate Representations and Color Texture: Follicular Lymphoma Grading , 2009, J. Signal Process. Syst..